Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas

Author： Blanc J.L.   Wager M.   Guilhot J.   Kusy S.   Bataille B.   Chantereau T.   Lapierre F.   Larsen C.J.   Karayan-Tapon L.  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.68, Iss.3, 2004-07, pp. : 275-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MGMT promoter methylation status in anaplastic meningiomas

By Brokinkel Benjamin   Fischer Bernhard   Peetz-Dienhart Susanne   Ebel Heinrich   Sepehrnia Abolghassem   Rama Burckhard   Albert Friedrich   Stummer Walter   Paulus Werner   Hasselblatt Martin  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 489-490

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation in malignant gliomas

By Riemenschneider Markus  

Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. : 161-165

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

By                      

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 654-658

Spandidos Publications

Access to resources Recommend Favorite

MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas

By Salehi Fateme  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 647-657

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation and temozolomide response in choroid plexus carcinoma

By Misaki Kouichi  

Brain Tumor Pathology, Vol. 28, Iss. 3, 2011-07 ,pp. : 259-263

Springer Publishing Company

Access to resources Recommend Favorite